Here's Why Viking Therapeutics Tumbled 20.9% in March
Shares of Viking Therapeutics (NASDAQ: VKTX) fell nearly 21% last month, according to data provided by S&P Global Market Intelligence. The coronavirus pandemic shocked stock markets around the globe, with the S&P 500 falling 12.5% in March.
While few companies were spared from a correction, small-cap stocks were among the worst performers. That's because smaller companies are generally not well positioned to endure prolonged periods of economic volatility. That might not be true for Viking Therapeutics, but the pharma stock faces near-term uncertainty nonetheless.
Image source: Getty Images.
Source Fool.com
